Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 5/20 | 0.47 |
| ▸ | HTR2A | P28223 | 3/20 | 0.47 |
| ▸ | HTR2B | P41595 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.42 |
| ▸ | DRD1 | P21728 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL161276 | 0.92 | TAAR1 (0.47) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| Glycolic Acid SCHEMBL162065 | 0.92 | TAAR1 (0.47) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| Adipic Acid SCHEMBL161399 | 0.90 | HTR2C (0.48) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| Adipic Acid SCHEMBL174687 | 0.90 | HTR2C (0.48) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| SCHEMBL162669 | 0.89 | HTR2C (0.57) | TAAR1HTR2CHTR2AHTR2BPRCP | |
| SCHEMBL163850 | 0.89 | HTR2C (0.57) | TAAR1HTR2CHTR2AHTR2BPRCP | |
| Fumaric Acid SCHEMBL159722 | 0.88 | TAAR1 (0.46) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| Maleic Acid SCHEMBL161822 | 0.88 | TAAR1 (0.46) | TAAR1HTR2CHTR2AHTR2BTSHR | |
| Bromide SCHEMBL161200 | 0.87 | HTR2C (0.56) | TAAR1HTR2CHTR2AHTR2BPRCP | |
| Iodide SCHEMBL162026 | 0.87 | HTR2C (0.56) | TAAR1HTR2CHTR2AHTR2BPRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2611449-A1 | ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT | Arena Pharmaceuticals, Inc. (US) | 2013-07-10 | — | — | EP | disclosed |
| WO-2012030953-A1 | 5-HT2C RECEPTOR AGONISTS IN THE TREATMENT OF DISORDERS AMELIORATED BY REDUCTION OF NOREPINEPHRINE LEVEL | ARENA PHARMACEUTICALS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |
| WO-2012030939-A1 | ADMINISTRATION OF LORCASERIN TO INDIVIDUALS WITH RENAL IMPAIRMENT | ARENA PHARMACEUTICALS, INC. (US) | 2012-03-08 | — | — | WO | disclosed |